Ignite Creation Date:
2025-12-18 @ 8:48 AM
Ignite Modification Date:
2025-12-18 @ 8:48 AM
Study NCT ID:
NCT01467271
Status:
None
Last Update Posted:
2019-02-04 00:00:00
First Post:
2011-11-04 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
Sponsor:
None
Organization:
Study Overview
Official Title:
Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
Status:
None
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NSsaFe
Brief Summary:
All patients will be followed up during 2 years after Dotarem® administration to collect data on any suspected NSF or NSF-related symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: